We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 28.00 | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSKIN
Integumen PLC
11 April 2017
Integumen plc
("Integumen")
Integumen signs first supply agreement in Asia
Integumen (LSE: SKIN), the personal health care company developing and commercialising technology and products for the human integumentary system is pleased to announce it has signed a strategic supply agreement for an initial term of three years with Mono Dent in South Korea for its oral hygiene products, which will establish an additional income stream from this new market.
Mono Dent is a leading distributor of oral hygiene products to dental surgeries and dental universities in South Korea. The agreement provides Mono Dent with the exclusive rights to distribute three products under the TSpro brand within South Korea. TSpro is a disposable tongue vacuum cleaner for professional use in the dental surgery, a tongue gel and a handle which turns the tongue vacuum cleaner into a tongue scraper for home-use. All products are marketed under the original brand "TS1".
Opening orders have been received for the TS1 professional product. As part of the exclusive agreement, Mono Dent has committed to a sales and marketing strategy for TS1 to penetrate further the South Korean market. South Korea has approximately 20,000 dental surgeries and is a growing market driven by medical tourism and cosmetic dental surgery.
Declan Service, CEO of Integumen, said:
"We are delighted to have secured our first supply agreement in Asia, and South Korea represents significant potential for future growth. TS1 is already being sold in parts of Europe and the Middle East and this agreement further validates this innovative product and our ability to enter new markets. We are actively seeking to launch TS1 in other markets, as we focus on growing our revenues for our commercialised products."
Declan Service, + 353 (0) 87 Integumen plc CEO 770 5506 ------------------------- ----------------------- --------------------------- SPARK Advisory Partners Limited Neil Baldwin/Sean +44 (0) 113 370 (Nominated Adviser) Wyndham-Quin 8974 ------------------------- ----------------------- --------------------------- Turner Pope Investments Ben Turner/James +44 (0) 20 3621 (TPI) Ltd Pope 4120 ------------------------- ----------------------- --------------------------- Cardew Group Shan Shan Willenbrock +44 (0) 20 7930 David Roach 0777 integumen@cardewgroup.com ------------------------- ----------------------- ---------------------------
About RNS Reach announcements
RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAKMGMDDGZGNZM
(END) Dow Jones Newswires
April 11, 2017 02:01 ET (06:01 GMT)
1 Year Integumen Chart |
1 Month Integumen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions